Author:
Ziemssen Tjalf,Hillert Jan,Butzkueven Helmut
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Nallamothu BK, Hayward RA, Bates ER. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation. 2008;118:1294–303.
2. Milnes F, Bergvall N, Olson M, Capkun-Niggli G, Bonzani I, Makin C. Use of real-world data to assess outcomes in patients with multiple sclerosis in a real-life clinical setting. 10th Annual Meeting of Health Technology Assessment international (HTAi). Seoul: Poster P1082; 2013.
3. Association of the British Pharmaceutical Industry. Demonstrating value with real world data: a practical guide. 2011. http://www.abpi.org.uk/our-work/library/guidelines/Pages/real-world-data.aspx . Accessed 25 February 2016.
4. Garrison Jr LP, Neumann PJ, Erickson P, Marshall D, Mullins CD. Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report. Value Health. 2007;10:326–35.
5. Ziemssen T, Kempcke R, Eulitz M, Grossmann L, Suhrbier A, Thomas K, Schultheiss T. Multiple sclerosis documentation system (MSDS): moving from documentation to management of MS patients. J Neural Transm (Vienna). 2013;120 Suppl 1:S61–6.
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献